Peptides
NA-Selank amidate: a modified calm peptide without clinical trials
What is it?
NA-Selank amidate is an N-acetylated and C-terminal amidated version of the Selank peptide. The changes may alter stability or distribution, but claims that they make it stronger or longer-acting require direct comparison studies. The name alone does not establish those effects. [1]
What do studies show?
A published small study compared unmodified Selank with medazepam in 62 patients with generalized anxiety disorder or neurasthenia. That provides limited, context-specific evidence for parent Selank; it does not establish that NA-Selank amidate reduces anxiety, improves cognition, or has the same effects at any route or dose. We did not identify a controlled human trial of the modified molecule. [2]
Safety
Mood or anxiety symptoms deserve assessment because effective established treatments exist. Safety observations from the parent drug cannot rule out different effects, impurities, or reactions from this modified research vial.
DOSE STATUS
How much?
EVIDENCE CONTEXT
Why?
The cited evidence does not establish a dose for this use or product.
There is no established effective and safe adult dose for NA-Selank amidate. The site’s Selank article describes an anecdotal amount for unmodified Selank, but that cannot be copied to a chemically modified analogue. We did not find a clearly attributable protocol for this exact form with enough formulation information to present as a meaningful anecdotal dose. [1,2]
Sources & further reading
- Amino Annex NA-Selank amidate listing (formulation label only) (opens in a new tab)www.aminoannex.com
- Parent Selank clinical comparison, 62 patients (opens in a new tab)pubmed.ncbi.nlm.nih.gov